Gantait Saikat, Mukherjee Eashan
Crop Research Unit (Genetics and Plant Breeding), Bidhan Chandra Krishi Viswavidyalaya, Mohanpur, Nadia, West Bengal, 741252, India.
J Genet Eng Biotechnol. 2021 Jan 8;19(1):4. doi: 10.1186/s43141-020-00109-8.
Induced polyploidy serves as an efficient approach in extricating genetic potential of cells. During polyploidization, multiple sets of chromosomes are derived from the same organism resulting in the development of an autopolyploid. Alterations owing to artificially induced polyploidy level significantly influence internal homeostatic condition of resultant cells.
Induced autopolyploidy transpires as a result of an increase in the size of genome without any change in elementary genetic material. Such autopolyploidy, artificially induced via application of antimitotic agents, brings about a lot of beneficial changes in plants, coupled with very few detrimental effects. Induced autopolyploids exhibit superior adaptability, endurance to biotic and abiotic stresses, longer reproductive period and enzyme diversity coupled with enhanced rate of photosynthesis and gene action in comparison to their diploid counterparts. However, reduced rate of transpiration and growth, delay in flowering are some of the demerits of autopolyploids. Inspite of these slight unfavourable outcomes, induced autopolyploidization has been utilized in an array of instances wherein genetic improvement of plant species is concerned, since this technique usually boosts the biomass of concerned economic parts of a plant. In other way, it is also evident that multiplication of genome bestows enhanced production of secondary metabolites, which has contributed to a significant commercial value addition especially for plants with medicinal importance, in particular.
This review makes an attempt to explore the system and success of antimitotic agents vis-à-vis artificial autopolyploidization, interfered with the biosynthesis-cum-production of secondary metabolites having cutting-edge pharmaceutical importance.
诱导多倍体是挖掘细胞遗传潜力的有效方法。在多倍体化过程中,多套染色体来源于同一生物体,从而产生同源多倍体。人工诱导的多倍体水平变化会显著影响所得细胞的内部稳态。
诱导同源多倍体的发生是由于基因组大小增加而基本遗传物质没有任何变化。这种通过应用抗有丝分裂剂人工诱导的同源多倍体,给植物带来了许多有益的变化,同时不利影响很少。与其二倍体对应物相比,诱导同源多倍体表现出更强的适应性、对生物和非生物胁迫的耐受性、更长的繁殖期和酶多样性,以及更高的光合作用速率和基因活性。然而,蒸腾速率和生长速率降低、开花延迟是同源多倍体的一些缺点。尽管有这些轻微的不利结果,但诱导同源多倍体化已在一系列涉及植物物种遗传改良的情况下得到应用,因为该技术通常会增加植物相关经济部位的生物量。另一方面,基因组的倍增也明显赋予了次生代谢产物产量的提高,这尤其为具有药用重要性的植物带来了显著的商业价值增加。
本综述试图探讨抗有丝分裂剂相对于人工同源多倍体化的体系和成功之处,其干扰了具有前沿药物重要性的次生代谢产物的生物合成及生产。